Skip to content
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
About Us
Investors
Our Investors
Dr. Jogin Desai
Founder and CEO
Gert Hoogland
CEO, Healthcrest Ventures
Oppel Greeff
Ex-Vice Chairman, Quintiles Transnational
Gillian Corken
Co-founder, Clindepharm International Pvt. Ltd
Dr. Ferzaan Engineer - Chairman
Cytespace Research - Investor
Endiya Partners
Dr. Rajani Battu
Co-founder & Chief Medical Officer
Alkem
Dr. Dhruv Sareen
Co-founder & Science Officer
Centre for Cellular and Molecular Platforms (C-CAMP)
Biotechnology Industry Research Council (BIRAC)
Mahyco Grow
Kemwell
Feather lite Developers
Investor Relation
Scheme of Arrangement
MOA & AOA
Accounting treatment certificate for amalgamation
Auditor Certificate - Accounting Treatment - ERPL
Audited financial statements of last three years
ERPL-Audit report FY 2022-23
ERPL-Audit report FY 2023-24
ERPL-Audit report FY 2024-25
ERPL-Standalone Financials FY 2022-23
ERPL-Standalone Financials FY 2023-24
ERPL-Standalone Financials FY 2024-25
Notice of NCLT convened meeting
ERPL-Notice to equity shareholders
ERPL-Notice to preference shareholders
NCLT Order
NCLT Order NKure Merger